Medlemstidning för Svensk Förening för Diabetologi

SSSD - Göteborg 23-25 maj, 1997

SSSD blir på Svenska Mässan i Göteborg 23-25 maj 1997. Satellitmöte planeras 22/5 1997 i Göteborg kring "Lipid disorders in NIDDM- implications for treatment". Det sker i Journal of Internal Medicine´s regi.
Välkommen!

22/5 1997 preliminärt program
Journal of Internal Medicine Symposium
09.00 Opening L-E Böttiger
09.05 Introduction Ulf Smith and Marja-Riitta Taskinen
09.10 Epidemiologic evidence for dyslipidemia as a risk factor for CHD in NIDDM Markku Laakso
10.30 Coffee
11.00 Which is the atherogenic lipoprotein in NIDDM? Mikko Syvänne
11.40 Dyslipidaemia and haemostatic abnormalities in NIDDM - relation to CHD Anders Hamsten
12.15 Lunch
13.30 Non-pharmacological therapy of lipid disorders in NIDDM Gabriele Riccardi
14.10 Current experience from hypolipaemic therapy in NIDDM Joseph Patsch
14.50 Coffee
15.20 Ongoing intervention trials in NIDDM George Steiner
16.00 Optimal target levels for lipids in NIDDM William Erkelens
16.40 Overall conclusions and recommendations Marja-Riitta Taskinen


Preliminärt program:

SSSD congress 23-25 maj 1997

Friday May 23
07.30-08.45Registration. Posters on place - available Friday-Sunday.
08.45-09.00Ulf Smith: Opening of the congress.
09.00-09.45Plenary lecture. Paul Zimmet:
The epidemiology and pathogenesis of diabetes in adults: Lessons from Asia and the South Pacific.
09.45-10.30Sam Cushman: Biology of the glucose transporting system.
10.30-11.00Coffee break
11.00-12.30Combination treatment with oral agents and insulin in NIDDM - a critical appraisal!
Debate between Hannele Yki-Järvinen and Philip Raskin
Yki-Järvinen: Bedtime NPH, Metformin and Self-Adjustment of the insulin dose (Self-AID):
A superior alternative in the treatment of NIDDM
Raskin: Sulfonylureas plus insulin ........why bother!
12.30-14.00Lunch + posters
SESSION 1
14.00-14.30State of the art Staffan Björck:
Diabetic nephropathy - what determines prognoses and how should we treat?
14.30-14.45Pettersson-Fernholm K, Fagerudd J, Grönhagen-Riska C, Groop PH:
Hypertension and NIDDM in parents is associated with diabetic nephropathy in offspring with NIDDM.
14.45-15.00Thorsby P, Hanssen KF, Kilhovd B, Rishaug U, Vaaler , Birkeland KI:
Progression of albuminuria relates to glycaemic control in subjects with NIDDM. A 5 year prospective study.
15.00-15.15Sørensen VB, Rossing P, Tarnow L, Parving HE, Nørgaard T, Kastrup J:
Differences between the effect of nisoldipine and lisinopril on microvascular dysfunction in hypertensive IDDM patients with nephropathy.
15.15-15.30Lindblom U, Eliasson B, Attvall S, Smith U:
Type II diabetic petients have faster gastric emptying than non-diabetic subjects.
SESSION 2
14.00-14.30State of the art Lennart Olsson:
Self-interacting extracellular motifs in control of insulin receptor internalization.
14.30-14.45Rondinone C, Carvalho E, Rahn T, Degerman E, Smith U:
Insulin stimulates the association of PI3-kinase serine kinase with theinsulin receptor and PDE3 is a substrate.
14.45-15.00
Andersen NA, Larsen CM, Mandrup-Poulsen T:
Effects of ILb, TNFa and IFNg on activation of the mitogen acivated protein kinases (MAPK) in isolated rat islets of langerhans.
15.00-15.15Hehenberger K, Brismar K, Kratz G, Johansson BL:
C-peptide increases proliferation in fibroblasts derived from IDDM patients.
15.15-15.30Dahlfors G, Chen Y, Gustafsson B, Arnqvist HJ:
Inhibitory effect of diabetes on proliferation of vascular smooth muscle after deendothelialization.
15.30-16.00Coffee
16.00-16.45Plenary lecture José Caro:
Update on leptin research
16.45-17.30Knut Lundbaek Award Rolf Luft Henning Beck-Nielsen:
Patophysiology of NIDDM 1997. "New players in an old game"
18.30-21.00Reception at the city hall Börsen, at Gustaf Adolfs Torg
Saturday May 24
08.00-08.45Plenary lecture (The Novo Nordisk Lecture) Arne Andersson:
On the biology of the transplanted pancreatic islets
08.45-09.30Edvin Gale: ????
09.30-10.00Coffee break
10.00-11.30Dyslipidemia in diabetes. Debate between Willem Erkelens and George Steiner.
Erkelens:
Feasibility of an aggressive treatment strategy for dyslipidemia in NIDDM.
Steiner:
Ongoing intervention trials in NIDDM.
11.30-13.00Lunch + posters
SESSION 3Pathogenesis of diabetes
13.00-13.15Carlsson ÅL, Tuomi T, Li H, Forsblom C, Nilsson A, Groop L and the Bothnia Research Group:
Lada differs at IDDM 1 and IDDM 2 LOCI from young-onset IDDM.
13.15-13.30Klannemark M, Orho M, Langin D, Laurell H, Holm C, Groop L:
Genetic interaction between the hormone-sensitive lipase gene and the metabolic syndrome.
13.30-13.45Lehto M, Bitzén PO, Carlsson M, Wessman Y, Wetterholz I, Groop L:
Diabetes in a Swedish family caused by a deletion in the HNF-4a (Mody1) gene.
13.45-14.00Pociot F, Larsen Z, Kristiansen OP, Johannesen J, Nerup J, DSGD, DIEGG:
IDDM13 at chromosome 2q34 is weakly linked to type 1 diabetes in the Danish population.
14.00-14.15Martikainen A, Savola K, Kulmala P, Ilonen J, Simell O. Knip M and the DIPP Study Group:
IDDM associated antibodies in cord blood samples from the general population.
14.15-14.30Karlsson M, Ludvigsson J:
Gad-peptide stimulates TH1, while abbos stimulates both TH1 and TH2 lymphocytes in diabetic children.
SESSION 4Metabolism
13.00-13.15Brundin T:
Splanchnic and extra-splanchnic insulin extraction during intravenous/after oral glucose administration.
13.15-13.30Poulsen P, Vaag A, Beck-Nielsen H:
Does zygosity status influence the metabolic profile in twins?
13.30-13.45Sjöstrand M, Holmäng A, Lönnroth P:
Lower interstitial muscle insulin concentration than in plasma during insulin infusion.
13.45-14.00Jansson PA, Sandfloo P, Lönnroth P:
Delayed insulin kinetics in adipose tissue in NIDDM patients - a microdialysis study.
14.00-14.15Nilsson C, Holmäng A, Lönnroth P:
The effects of glucosamine on muscle glucose metabolism and blood flow.
14.15-14.30Eliasson B, Smith U:
The insulin resistance syndrome in smokers.
14.30-15.00Coffee break
15.00-15.45Dean Londos:
Redefining the lipid storage droplet: A dynamic subcellular compartment and its associated proteins.
SESSION 5Hypoglycemia and glucosecontrol
15.45-16.00Orho M, Åberg M, Buist N, Bosshard NU, Gitzelmann R, Bodurtha J, Groop L:
Mutations in the liver glycogen synthase gene in children with infantile hypoglycemia.
16.00-16.15Wahren J, Ekberg K, Fernqvist-Forbes E, Nair S:
Brain substrate utilization during hypoglycemia.
16.15-16.30Axelsen M, Wesslau C, Lönnroth P, Smith U:
Reduced number of hypoglycemic events at night by bedtime cornstarch supplement in intensively treated IDDM subjects.
16.30-16.45Landstedt-Hallin L, Englund A, Adamson U, Lins PE:
Increased QT- dispersion during hypoglycemia in NIDDM patients with and without glibenclamide treatment.
16.45-17.00Julsrud Berg T, Torjesen PA, Thorn Clausen J, Dahl-Jørgensen K, Bangstad HJ, Vogt H, Hanssen KF:
Increased serum levels of the glycoxidation product Ne-(carboxymethyl)lysine (CML) in children and adolescents with IDDM.
17.00-17.15Wahren J, Bertorello A, Johansson BL, Halban PA, Jörnvall H:
Fragments of rat C-peptide stimulate b-cell Na+, K+- ATPase activity.
SESSION 6Insulin secretion and b-cells
15.45-16.00Westermark G, Leckstöm A, Ma Z, Westermark P:
Increased release of IAPP in mice fed a high fat diet.
16.00-16.15Holstad M, Sandler S:
Protection against hyperglycemia in mice, injected with multiple low doses of streptozotocin, by a transcriptional inhibitor of TNF-a.
16.15-16.30Sandler S, Eizirik DL, Sandberg JO:
Interleukin-1 receptor antagonist prevents recurrence of disease after syngeneic islet transplantation to diabetic nod mice.
16.30-16.45Jansson L, Iwase M, Carlsson PO:
Hepatic glucoreceptors affect pancreatic islet blood flow through the nervous system.
16.45-17.00Karlsen AE, Nielsen K, Jensen J, Andersen HU, Mandrup-Poulsen T, Madsen OD, Nerup J:
Cytokine induction of interleukin-1 converting enzyme (ICE), inducible nitric oxide synthase (INOS) and apoptosis in beta-cells.
17.00-17.15Larsen CM, Wadt K, Juhl LF, Andersen HU, Seedorf K, Su M, Shapiro L, Dinarello CA, Mandrup-Poulsen T:
Inhibition of ERK1/2 and p38 mitogen activated protein kinase (MAPK) blocks IL-1 induced rat islets nitric oxide (NO) synthesis.
17.15-17.45General Assembly
19.30Congress Banquet at the Park Avenue Hotel
SESSION FÖR DIABETESSKÖTERSKOR
10.00-12.30Livskvalitet och coping
Marianne Sullivan: Livskvalitetsmätning - begrepp och metoder.
Lars-Olof Persson: Copingstrategier vid kronisk sjukdom.
Karin Wikblad: Livskvalitet hos typ 1 och typ 2 diabetiker - en jämförelse.
Jan-Olof Hörnquist: Typ 1 diabetes, livskvalitet och coping - en prospektiv longitudinell studie.
12.30-13.30Lunch
13.30-15.30Livsstilsförändringar vid typ 2 diabetes
Moy Ofdahl-Brand, Ingela Melin:
Varför gör dom inte som vi säger? Att prata levnadsvanor med patienten. Övervikt och diabetes - beteendemodifikation och konventionell behandling i grupp.
Sunday May 25
09.00-09.45Carl-David Agardh:
Fourth meeting for the implementation of the St Vincent Declaration. A report from the St Vincent meeting in Lissabon.
09.45-10.30Anders Nilsson:
Outcome data from the Swedish National Diabetes Register.
10.30-11.00Coffee break
11.00-11.45Young Investigators Award Elisabeth Björck Jan Jensen
11.45Closure
12.00Lunch

Deadline för abstract är 970301 och för reducerad registreringsavgift 970401.
Fax nummer för mer INFO 031 82 53 30, tfn nr 031 60 11 04,
birgitta.ahlden@medicine.gu.se
President är prof Ulf Smith.

SSSD inbjuder diabetessköterskor 23-25/5.
Två sessioner ägnas åt:
1) Livskvalitet och coping-strategier; begrepp, mätmetoder, resultat av studier gjorda på diabetiker. Medverkande är bland annat Marianne Sullivan och Lars Olof Persson, Göteborg, Karin Wikblad, Falun.
2) Att prata levnadsvanor, övervikt och diabetes; Ingela Melin och Moy Ofdahl-Brandt, Stockholm.


Till Förstasidan